Advertisement

ASCO GI 2023

New Standard of Care for Colorectal Cancer

Jan 27, 2023

REFERENCES & ADDITIONAL READING

  1. Tabernero J, et al. Trifluridine/tipiracil plus bevacizumab for third-line treatment of refractory metastatic colorectal cancer: The phase 3 randomized SUNLIGHT study. Abstract 4, ASCO GI 2023, 19–21 January, San Francisco, CA, USA.

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement